These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12520978)

  • 1. Genetic advances in coronary artery disease.
    Wung SF
    Medsurg Nurs; 2002 Dec; 11(6):296-300. PubMed ID: 12520978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential nursing competencies for genetics and genomics: implications for critical care.
    Howington L; Riddlesperger K; Cheek DJ
    Crit Care Nurse; 2011 Oct; 31(5):e1-7. PubMed ID: 21965389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care of the Patient Undergoing Radial Approach Heart Catheterization: Implications for Medical-Surgical Nurses.
    Gomes BR
    Medsurg Nurs; 2015; 24(3):173-6. PubMed ID: 26285381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis in cardiovascular disease: a clinical perspective.
    Ho E; Bhindi R; Ashley EA; Figtree GA
    Cardiol Rev; 2011; 19(2):81-9. PubMed ID: 21285668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.
    Brugts JJ; de Maat MP; Boersma E; Witteman JC; van Duijn C; Uitterlinden AG; Bertrand M; Remme W; Fox K; Ferrari R; Danser AH; Simoons ML;
    Cardiovasc Drugs Ther; 2009 Apr; 23(2):171-81. PubMed ID: 19082699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of response to statins.
    Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene-environment interaction in coronary artery disease.
    Humphries SE; Donati MB
    Ital Heart J; 2002 Jan; 3(1):3-5. PubMed ID: 11899587
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary care strategies to reduce the risk of coronary heart disease.
    Nuttall M
    Prof Nurse; 2002 Jul; 17(11):679-81. PubMed ID: 12138586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating Genomic Advances to Physical Therapist Practice: A Closer Look at the Nature and Nurture of Common Diseases.
    Curtis CL; Goldberg A; Kleim JA; Wolf SL
    Phys Ther; 2016 Apr; 96(4):570-80. PubMed ID: 26637647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications.
    Seo D; Ginsburg GS; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2006 Jul; 48(2):227-35. PubMed ID: 16843168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and heart disease.
    Chamsi Pasha H
    Saudi Med J; 2003 Jan; 24(1):11-8. PubMed ID: 12590266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A revolution in genetics: changing medicine, changing lives.
    Bottles K
    Physician Exec; 2001; 27(2):58-63. PubMed ID: 11291222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived knowledge and clinical comfort with genetics among Taiwanese nurses enrolled in a RN-to-BSN program.
    Hsiao CY; Lee SH; Chen SJ; Lin SC
    Nurse Educ Today; 2013 Aug; 33(8):802-7. PubMed ID: 22464631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.
    Brugts JJ; Isaacs A; Boersma E; van Duijn CM; Uitterlinden AG; Remme W; Bertrand M; Ninomiya T; Ceconi C; Chalmers J; MacMahon S; Fox K; Ferrari R; Witteman JC; Danser AH; Simoons ML; de Maat MP
    Eur Heart J; 2010 Aug; 31(15):1854-64. PubMed ID: 20538738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of the American Heart Association's scientific statement on the relevance of genetics and genomics for prevention and treatment of cardiovascular disease.
    Arnett DK;
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1682-6. PubMed ID: 17634522
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenetics of multigenic disease: heart disease as an example.
    Cooke GE
    Vascul Pharmacol; 2006 Feb; 44(2):66-74. PubMed ID: 16376619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new world view of genetics service models.
    Lea DH
    Online J Issues Nurs; 2000; 5(3):5. PubMed ID: 11380272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [I/D polymorphism of the ACE gene: a cardiovascular risk marker or error in molecular genetics?].
    Cesari M; Rossi GP
    G Ital Cardiol; 1997 Oct; 27(10):1044-52. PubMed ID: 9410774
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy.
    Brugts JJ; Danser AH; de Maat MP; den Uil CA; Boersma E; Ferrari R; Simoons ML
    Curr Opin Cardiol; 2008 Jul; 23(4):296-301. PubMed ID: 18520711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.